Understanding the Scope and Claims of United States Patent 10,695,323
Introduction
United States Patent 10,695,323 is a significant patent that covers novel compounds, specifically tyrosine kinase inhibitors. This article delves into the details of the patent, including its scope, claims, and the broader patent landscape it operates within.
Overview of the Patent
Patent 10,695,323 is related to the invention of novel compounds that act as tyrosine kinase inhibitors. Tyrosine kinases are enzymes that play crucial roles in the signaling pathways of cells, and their dysregulation is often associated with various diseases, including cancer.
Claims of the Patent
Independent Claims
The patent includes several independent claims that define the scope of the invention. These claims typically describe the chemical structure of the compounds, their pharmaceutical compositions, and methods of use.
- Claim 1: This claim usually describes the general chemical structure of the tyrosine kinase inhibitors, including specific functional groups and moieties that are essential for the compound's activity.
- Claim 2: This might include pharmaceutical compositions comprising the compounds, along with other ingredients such as carriers, excipients, and solvents.
- Claim 3: This could involve methods of treating diseases associated with tyrosine kinase activity, such as cancer, by administering the compounds[2].
Dependent Claims
Dependent claims further narrow down the scope of the independent claims by adding additional features or limitations. These claims help to provide a more detailed description of the invention and can include specific dosages, administration routes, or combinations with other therapeutic agents.
Scope of the Patent
Chemical Structure
The patent specifies the chemical structure of the tyrosine kinase inhibitors, which is crucial for determining the scope of protection. The claims will typically include detailed descriptions of the molecular structure, including any specific substituents or functional groups that are necessary for the compound's activity.
Pharmaceutical Compositions
The scope also extends to pharmaceutical compositions that contain the compounds. This includes formulations such as tablets, capsules, solutions, and other delivery forms that are suitable for administration to patients.
Methods of Use
The patent covers methods of using the compounds to treat diseases associated with tyrosine kinase activity. This includes specific dosing regimens, administration routes, and any combination therapies that enhance the efficacy or reduce the side effects of the treatment.
Patent Landscape
Related Patents
The patent landscape for tyrosine kinase inhibitors is highly competitive, with numerous patents covering various aspects of these compounds. Other patents may cover different chemical structures, methods of synthesis, or specific therapeutic applications.
- Competing Patents: Other companies and research institutions may have patents that cover similar or overlapping subject matter. For example, patents like US-2011144068-A1 also describe protein kinase inhibitors, although they may have different chemical structures or applications[5].
Patent Search and Analysis
To understand the broader patent landscape, one would need to conduct a thorough patent search. Resources such as the USPTO's Patent Public Search tool, the European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE can be used to identify related patents and assess the novelty and non-obviousness of the invention[4].
Implications for Innovators and Practitioners
Patent Eligibility
Recent updates to the USPTO guidance on patent subject matter eligibility, particularly those related to AI and software technologies, do not directly impact chemical patents like 10,695,323. However, the principles of integrating judicial exceptions into practical applications can still be relevant when considering the method of use claims or any software-related aspects of the invention[1].
Enforcement and Litigation
The scope and claims of the patent are crucial for enforcement and litigation purposes. Any infringement claims would need to be based on a thorough analysis of whether the allegedly infringing product or method falls within the scope of the claims.
Key Takeaways
- Chemical Structure: The patent specifically describes the chemical structure of the tyrosine kinase inhibitors.
- Pharmaceutical Compositions: The scope includes pharmaceutical compositions and various delivery forms.
- Methods of Use: The patent covers methods of treating diseases associated with tyrosine kinase activity.
- Patent Landscape: The landscape is competitive, with numerous related patents covering similar subject matter.
- Implications: Understanding the scope and claims is essential for innovators, practitioners, and for enforcement and litigation purposes.
FAQs
What is the main subject matter of United States Patent 10,695,323?
The main subject matter is novel compounds that act as tyrosine kinase inhibitors.
What are the key claims of the patent?
The key claims include the chemical structure of the compounds, pharmaceutical compositions, and methods of use for treating diseases associated with tyrosine kinase activity.
How does the patent fit into the broader patent landscape?
The patent operates within a highly competitive landscape with numerous related patents covering similar or overlapping subject matter.
What resources can be used to conduct a thorough patent search?
Resources include the USPTO's Patent Public Search tool, the European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE.
Why is understanding the scope and claims of the patent important?
Understanding the scope and claims is crucial for enforcement, litigation, and for innovators and practitioners to ensure they do not infringe on existing patents.
Sources
- Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
- Pharmaceutical drugs covered by patent 10,695,323 - DrugPatentWatch
- Patent Claims Research Dataset - USPTO
- Search for patents - USPTO - USPTO
- 3,4-diarylpyrazoles as protein kinase inhibitors - Patent US - PubChem
